Advertisement
Screener

InspireMD, Inc. (NSPR) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum

InspireMD, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum

InspireMD, Inc. (NSPR) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum of 3.45% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-18.

Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum · last filed 2026-03-18

  • InspireMD, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, minimum for the quarter ending 2023-03-31 was 3.65%, a 103.91% increase year-over-year.
  • InspireMD, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, minimum for the quarter ending 2022-03-31 was 1.79%.
  • InspireMD, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, minimum for fiscal 2025 was 3.45%, a 12.21% decline from fiscal 2024.
  • InspireMD, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, minimum for fiscal 2024 was 3.93%, a 9.78% increase from fiscal 2023.
  • InspireMD, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, minimum for fiscal 2023 was 3.58%, a 100.00% increase from fiscal 2022.
  • InspireMD, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, minimum for fiscal 2022 was 1.79%, a 203.39% increase from fiscal 2021.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum 12 month
2025-12-313.45%
10-K · filed 2026-03-18
2024-12-313.93%
10-K · filed 2026-03-18
2023-12-313.58%
10-K · filed 2025-03-12
2023-03-313.65%
10-Q · filed 2023-05-15
2022-12-311.79%
10-K · filed 2024-03-05
2022-09-301.79%
10-Q · filed 2022-11-07
2022-06-301.79%
10-Q · filed 2022-08-08
2022-03-311.79%
10-Q · filed 2022-05-09
2021-12-310.59%
10-K · filed 2023-03-30
2020-12-310.32%
10-K · filed 2022-03-07
2016-06-301.01%
10-Q · filed 2016-08-09

Similar stocks

Stock NameCountryMarket CapPE Ratio
PAVmed Inc. (PAVM)United States$0.031B-3.00
Glucotrack, Inc. (GCTK)United States$0.027B
ACCURAY INC (ARAY)United States$0.027B-0.63
SANUWAVE Health, Inc. (SNWV)United States$0.041B5.47
HeartBeam, Inc. (BEAT)United States$0.022B-2.08
RETRACTABLE TECHNOLOGIES INC (RVP)United States$0.021B-6.44
FEMASYS INC (FEMY)United States$0.020B-1.07
NEPHROS INC (NEPH)United States$0.046B23.02
Modular Medical, Inc. (MODD)United States$0.018B-0.88
Sensus Healthcare, Inc. (SRTS)United States$0.048B-3.24